SCHEMBL5680434

SCHEMBL5680434

COc1ccc2[nH]cc(CN(C)C)c2c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.53
HTR2A P28223 3/20 0.50
HTR2C P28335 2/20 0.50
HTR2B P41595 2/20 0.50
HTR6 P50406 3/20 0.49
ALDH1A1 P00352 3/20 0.44
CYP2D6 P10635 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MTNR1A P48039 2/20 0.40
MTNR1B P49286 2/20 0.40
HTR7 P34969 2/20 0.40
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25145335 0.85 HTR1A (0.73) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL1196109 0.84 HTR1A (0.75) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL8546408 0.84 HTR1A (0.52) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL29445150 0.80 HTR6 (0.74) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL13390751 0.80 HTR6 (0.74) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL25747860 0.79 HTR1A (0.57) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL1971484 0.79 HTR2A (0.67) HTR1AHTR2AHTR2CHTR6MEN1
SCHEMBL30483740 0.78 HTR1A (0.56) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL25424142 0.78 HTR1A (0.56) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL5680499 0.78 HTR1A (0.43) HTR1AHTR2AHTR2BHTR6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084154-B2 2-(aminomethyl) arylamide analgesics PHARMACOPEIA DRUG DISCLOVERY, INC. (US) 2006-08-01 US disclosed
US-20040167119-A1 2-(aminomethyl) arylamide analgesics PHARMACOPEIA, INC (US) 2004-08-26 US disclosed
WO-2004071445-A2 2-(AMINOMETHYL)ARYLAMIDE ANALGESICS PHARMACOPEIA DRUG DISCOVERY, INC. (US) 2004-08-26 WO disclosed
WO-2004071445-A2 2-(AMINOMETHYL)ARYLAMIDE ANALGESICS PHARMACOPEIA DRUG DISCOVERY, INC. (US) 2004-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167119-A1 2-(aminomethyl) arylamide analgesics OPRL1, OPRM1, OPRK1 HTR1A 65/4885HTR2A 28/4885HTR2C 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.